{ "format" : "linked-data-api", "version" : "0.2", "result" : {"_about" : "http://eldaddp.azurewebsites.net/answeredquestions.text?answeringDeptSortName=Health+and+Social+Care&uin=HL5202", "definition" : "http://eldaddp.azurewebsites.net/meta/answeredquestions.text?answeringDeptSortName=Health+and+Social+Care&uin=HL5202", "extendedMetadataVersion" : "http://eldaddp.azurewebsites.net/answeredquestions.text?answeringDeptSortName=Health+and+Social+Care&uin=HL5202&_metadata=all", "first" : "http://eldaddp.azurewebsites.net/answeredquestions.text?_page=0&answeringDeptSortName=Health+and+Social+Care&uin=HL5202", "hasPart" : "http://eldaddp.azurewebsites.net/answeredquestions.text?answeringDeptSortName=Health+and+Social+Care&uin=HL5202", "isPartOf" : "http://eldaddp.azurewebsites.net/answeredquestions.text?answeringDeptSortName=Health+and+Social+Care&uin=HL5202", "items" : [{"_about" : "http://data.parliament.uk/resources/1581665", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"} ], "answer" : {"_about" : "http://data.parliament.uk/resources/1581665/answer", "answerText" : {"_value" : "

<\/strong>The Government continues to be guided by the independent Joint Committee on Vaccination and Immunisation (JCVI) on who should be offered COVID-19 vaccinations. On 6 December 2022, the Medicine and Healthcare products Regulatory Agency approved the COVID-19 vaccine Pfizer infant formulation (Comirnaty 3) for children aged six months to four years old. The JCVI\u2019s advice will be published in due course on whether COVID-19 vaccination should be offered to any children in this age group now that a vaccine is available.<\/p>

People who were five years old or older as of 31 August 2022 are currently eligible for primary vaccination and those aged 16 or over are also entitled to an initial booster. Those who are at higher risk of serious outcomes from COVID-19 are eligible for a further seasonal booster under the current autumn campaign.<\/p>

The autumn booster campaign will close in England on 12 February 2023, as will the offer of an initial booster for persons aged 16 to 49 years who are not in a clinical risk group. We encourage everyone currently eligible to come forward before these offers close.<\/p>

In line with the JCVI\u2019s advice, the primary course offer of COVID-19 vaccination will now move towards a more targeted offer limited to vaccination campaigns for those at higher risk of severe COVID-19. This means that the offer of primary vaccination will end for those aged under 50 who are not in an at-risk group. The Government is considering when during 2023 this recommendation should be implemented. The JCVI continues to review evidence and will provide further advice regarding the 2023 vaccination programmes in due course.<\/p>"} , "answeringMember" : {"_about" : "http://data.parliament.uk/members/4948", "label" : {"_value" : "Biography information for Lord Markham"} } , "answeringMemberPrinted" : {"_value" : "Lord Markham"} , "dateOfAnswer" : {"_value" : "2023-02-08", "_datatype" : "dateTime"} , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"} , "questionFirstAnswered" : [{"_value" : "2023-02-08T17:52:40.09Z", "_datatype" : "dateTime"} ]} , "answeringDeptId" : {"_value" : "17"} , "answeringDeptShortName" : {"_value" : "Health and Social Care"} , "answeringDeptSortName" : {"_value" : "Health and Social Care"} , "date" : {"_value" : "2023-01-30", "_datatype" : "dateTime"} , "hansardHeading" : {"_value" : "Coronavirus: Vaccination"} , "houseId" : {"_value" : "2"} , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25277", "prefLabel" : {"_value" : "House of Lords"} } ], "questionText" : "To ask His Majesty's Government what assessment they have made of giving (1) children under five years old, and (2) adults under 50 years old, access to COVID-19 vaccines.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"} , "tablingMember" : {"_about" : "http://data.parliament.uk/members/4216", "label" : {"_value" : "Biography information for Lord Empey"} } , "tablingMemberPrinted" : [{"_value" : "Lord Empey"} ], "uin" : "HL5202"} , {"_about" : "http://data.parliament.uk/resources/1200298", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"} ], "answer" : {"_about" : "http://data.parliament.uk/resources/1200298/answer", "answerText" : {"_value" : "

To provide a more comprehensive response to a number of outstanding Written Questions, this has been answered by an information factsheet Testing \u2013 note for House of Lords<\/em> which is attached, due to the size of the data. A copy has also been placed in the Library<\/p>

<\/p>"} , "answeringMember" : {"_about" : "http://data.parliament.uk/members/4708", "label" : {"_value" : "Biography information for Lord Bethell"} } , "answeringMemberPrinted" : {"_value" : "Lord Bethell"} , "attachment" : {"_about" : "http://data.parliament.uk/resources/1200298/answer/attachment/1", "fileName" : {"_value" : "Testing - note for House of Lords.pdf"} , "title" : "Testing information factsheet"} , "dateOfAnswer" : {"_value" : "2020-07-29", "_datatype" : "dateTime"} , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"} , "questionFirstAnswered" : [{"_value" : "2020-07-29T15:51:36.203Z", "_datatype" : "dateTime"} ]} , "answeringDeptId" : {"_value" : "17"} , "answeringDeptShortName" : {"_value" : "Health and Social Care"} , "answeringDeptSortName" : {"_value" : "Health and Social Care"} , "date" : {"_value" : "2020-06-03", "_datatype" : "dateTime"} , "hansardHeading" : {"_value" : "Health Services: Coronavirus"} , "houseId" : {"_value" : "2"} , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25277", "prefLabel" : {"_value" : "House of Lords"} } ], "questionText" : "Her Majesty's Government what steps they are taking to balance COVID-19 and non-COVID-19 care and treatment; whether those steps include making systemic and consistent testing available for patients and staff; and if not, how they plan to ensure the provision of all care and treatment without such testing.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"} , "tablingMember" : {"_about" : "http://data.parliament.uk/members/4203", "label" : {"_value" : "Biography information for Baroness Jolly"} } , "tablingMemberPrinted" : [{"_value" : "Baroness Jolly"} ], "uin" : "HL5202"} , {"_about" : "http://data.parliament.uk/resources/832879", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"} ], "answer" : {"_about" : "http://data.parliament.uk/resources/832879/answer", "answerText" : {"_value" : "

On 25 January 2017, the Yeovil District Hospital NHS Foundation Trust board approved work to examine the case for establishing a wholly owned subsidiary for estates and facilities management. On 20 December 2017, after staff consultation had taken place, the Trust board approved the formation of a wholly owned subsidiary.<\/p>

NHS Improvement has reviewed key relevant documents including the Trust board paper evidencing informal staff engagement about the proposed changes during October 2017, as well as a formal 30-day staff consultation during November 2017. Following the staff consultation, the Trust made changes to its proposal which benefitted the staff transferring to the new company. The Trust has confirmed to NHS Improvement that it took legal advice in relation to its duty to consult staff on the changes.<\/p>

<\/p>

The Trust did not establish the wholly-owned subsidiary prior to consulting clinical commissioning groups (CCGs). NHS Improvement has seen correspondence from Somerset CCG on 19 December 2017 giving permission for the wholly-owned subsidiary to be a permitted subcontractor. NHS Improvement has seen similar correspondence from NHS England Specialised Commissioners on 22 November 2017 approving the wholly-owned subsidiary as a permitted subcontractor. The Trust board took the decision to approve the formation of the wholly owned subsidiary on 20 December 2017.<\/p>

Yeovil District Hospital NHS Foundation Trust has told NHS Improvement that it has not been necessary to spend additional time beyond normal Board business discussing clinical matters as a result of establishing a wholly-owned subsidiary company.<\/p>

<\/p>"} , "answeringMember" : {"_about" : "http://data.parliament.uk/members/4545", "label" : {"_value" : "Biography information for Lord O'Shaughnessy"} } , "answeringMemberPrinted" : {"_value" : "Lord O'Shaughnessy"} , "dateOfAnswer" : {"_value" : "2018-02-08", "_datatype" : "dateTime"} , "groupedQuestionUIN" : [{"_value" : "HL5199"} , {"_value" : "HL5200"} , {"_value" : "HL5201"} ], "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"} , "questionFirstAnswered" : [{"_value" : "2018-02-08T12:33:14.82Z", "_datatype" : "dateTime"} ]} , "answeringDeptId" : {"_value" : "17"} , "answeringDeptShortName" : {"_value" : "Health and Social Care"} , "answeringDeptSortName" : {"_value" : "Health and Social Care"} , "date" : {"_value" : "2018-01-29", "_datatype" : "dateTime"} , "hansardHeading" : {"_value" : "Yeovil District Hospital NHS Foundation Trust"} , "houseId" : {"_value" : "2"} , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25277", "prefLabel" : {"_value" : "House of Lords"} } ], "questionText" : "To ask Her Majesty's Government what estimate has been made of the additional time spent by the Yeovil District Hospital NHS Foundation Trust Board discussing clinical matters as a result of establishing a wholly-owned subsidiary company to run estates and other support services.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"} , "tablingMember" : {"_about" : "http://data.parliament.uk/members/2024", "label" : {"_value" : "Biography information for Lord Hunt of Kings Heath"} } , "tablingMemberPrinted" : [{"_value" : "Lord Hunt of Kings Heath"} ], "uin" : "HL5202"} ], "itemsPerPage" : 10, "page" : 0, "startIndex" : 1, "totalResults" : 3, "type" : ["http://purl.org/linked-data/api/vocab#ListEndpoint", "http://purl.org/linked-data/api/vocab#Page"]} }